Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada

被引：22
|
作者：
Labbé, AC [1 ]
Bourgault, AM [1 ]
Vincelette, J [1 ]
Turgeon, PL [1 ]
Lamothe, F [1 ]
机构：
[1] CHU Montreal, Dept Microbiol Med & Infectiol, Montreal, PQ H2X 3J4, Canada
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 10期
关键词：
D O I：
10.1128/AAC.43.10.2517
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The objective of the present study was to analyze the susceptibility profiles of 911 clinical strains of the Bacteroides fragilis group isolated from 1992 to 1997 in our institution in order to monitor susceptibility changes over time. Whereas the rates of resistance to metronidazole, imipenem, piperacillin-tazobactam, ticarcillin-clavulanic acid, penicillin, piperacillin, and cefoxitin remained essentially unchanged, there was a significant increase in the rates of resistance to clindamycin, which rose from 8.2% in 1992 to 19.7% in 1997 (P < 0.0004).
引用
收藏
页码：2517 / 2519
页数：3
相关论文
共 50 条
  • [1] Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994
    Snydman, DR
    McDermott, L
    Cuchural, GJ
    Hecht, DW
    Iannini, PB
    Harrell, LJ
    Jenkins, SG
    OKeefe, JP
    Pierson, CL
    Rihs, JD
    Yu, VL
    Finegold, SM
    Gorbach, SL
    CLINICAL INFECTIOUS DISEASES, 1996, 23 : S54 - S65
  • [2] Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance Study
    Karlowsky, James A.
    Walkty, Andrew J.
    Adam, Heather J.
    Baxter, Melanie R.
    Hoban, Daryl J.
    Zhanel, George G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) : 1247 - 1252
  • [3] Antimicrobial resistance profile of Bacteroides fragilis group of clinical isolates, eastern India
    Mohanty, Srujana
    Rath, Sutapa
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 39 (03) : 397 - 398
  • [4] Bacteroides fragilis group:: Trends in resistance
    Fille, M
    Mango, M
    Lechner, M
    Schaumann, R
    CURRENT MICROBIOLOGY, 2006, 52 (02) : 153 - 157
  • [5] Bacteroides fragilis Group: Trends in Resistance
    Manfred Fille
    Monica Mango
    Matthias Lechner
    Reiner Schaumann
    Current Microbiology, 2006, 52 : 153 - 157
  • [6] Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary
    Nagy, E
    Sóki, J
    Urbán, E
    Szöke, I
    Fodor, E
    Edwards, R
    ACTA BIOLOGICA HUNGARICA, 2001, 52 (2-3): : 271 - 280
  • [7] Occurrence of Metronidazole and Imipenem Resistance Among Bacteroides fragilis Group Clinical Isolates in Hungary
    Elisabeth Nagy
    J. Sóki
    Edit Urbán
    Ildikó Szőke
    Eleonóra Fodor
    R. Edwards
    Acta Biologica Hungarica, 2001, 52 : 271 - 280
  • [8] Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group:: time to be concerned?
    Brazier, JS
    Stubbs, SLJ
    Duerden, BI
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) : 580 - 581
  • [9] Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe
    Hedberg, M
    Nord, CE
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) : 475 - 488
  • [10] Antimicrobial resistance, prevalence of resistance genes, and molecular characterization in intestinal Bacteroides fragilis group isolates
    Kouhsari, Ebrahim
    Mohammadzadeh, Nima
    Kashanizadeh, Mohammad Ghasem
    Saghafi, Mohammad Mehdi
    Hallajzadeh, Masoumeh
    Fattahi, Azam
    Ahmadi, Alireza
    Niknejad, Farhad
    Ghafouri, Zahra
    Asadi, Arezoo
    Nasrabadi, Mohammad Reza Boujary
    APMIS, 2019, 127 (06) : 454 - 461
12345